Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study
暂无分享,去创建一个
P. Richardson | P. Moreau | Jing Liu | Jie Jin | J. Hou | Depei Wu | X. Ke | Xin Du | Xiequn Chen | Bingxia Wang | Z. Hua | Jin Lu | Yan Xu | N. Gupta | Dao-bin Zhou | M. Hanley | Junmin Li | Xiaoquan Zhang | Hui Wang | H. V. D. van de Velde | Hongmei Li | X. Du | Zhaowei Hua